Although the use of EGFR inhibitors did not prolong survival or increase myeloid differentiation in an APL mouse model sensitive to ATRA, gefitinib stimulated apoptosis, inhibited cell proliferation, and re-sensitized ATRA- and ATO-resistant APL cells to ATRA and ATO induced differentiation, respectively. Here, EGFR is linked to acute promyelocytic leukemia.